ACCP collaborates with ASHP on Infectious Diseases Pharmacy activities.
Series Overview
The Literature Study Module provides immediate access to peer-selected, contemporary articles that are relevant to specialty practice. After learners review the content, they must successfully complete an online assessment to earn recertification credit.
Release date: April 15, 2020
BCIDP credit expiration date: October 20, 2020
ACPE credit expiration date: October 20, 2020
Activity Overview
The Literature Study Module is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). This module consists of 2 online home study activities (see table below). Each activity is designed to assess the learners’ ability to analyze and apply peer-selected contemporary articles to practice.
Module 1A – HIV and Hepatitis C: This module focuses on pre- and post-exposure prophylaxis of HIV, as well as management of patients with HIV and/or Hepatitis C.
Module 1B – Infectious Diseases Potpourri: This module focuses on new information that is important to the infectious diseases pharmacist, including management of penicillin allergy, considering recombinant zoster vaccine in immunosuppressed patients, and prevention and management of tuberculosis.
Learners will be required to review the content and complete the associated online assessments. The learner must be able to correctly answer the questions based upon their interpretation of the content, as well as “baseline specialty specific knowledge and/or easily retrievable information.” For purposes of this Literature Study, “baseline specialty specific knowledge and/or easily retrievable information” is defined as product labeling and well-established standards of practice in the specialty practice.
These activities are part of the ASHP and ACCP professional development program for BCIDP recertification approved by the BPS.
Faculty
Heather Cox Hall, Pharm.D., BCPS-AQ ID, BCIDP
Lead Pharmacist, Infectious Diseases
University of Virginia Health System
Charlottesville, Virginia
Steve C. Ebert, B.S.Pharm., Pharm.D., FCCP, FIDSA, BCIDP
Clinical Pharmacy Manager, Infectious Diseases
Department of Pharmacy
UnityPoint Health-Meriter Hospital
Madison, Wisconsin
Sarah M. Michienzi, Pharm.D., BCPS, AAHIVP
Clinical Assistant Professor
Department of Pharmacy Practice
College of Pharmacy
University of Illinois at Chicago
Chicago, Illinois
Trent G. Towne, Pharm.D., BCPS
Associate Professor of Pharmacy Practice
Manchester University College of Pharmacy
Fort Wayne, Indiana
Content Matter Experts
Snehal Bhatt, Pharm.D., BCPS
Associate Professor of Pharmacy Practice
Massachusetts College of Pharmacy and Health Science
Clinical Pharmacist
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Kevin W. Garey, Pharm.D., M.S., FASHP
Professor and Chair
University of Houston
Houston, Texas
Jason Schafer, Pharm.D., M.P.H., AAHIVP, BCPS
Associate Professor, Department of Pharmacy Practice
Jefferson College of Pharmacy, Thomas Jefferson University
Philadelphia, Pennsylvania
Douglas Slain, Pharm.D., B.S.Pharm., BCPS, FASHP
Professor and Infectious Diseases Clinical Specialist
West Virginia University (WVU) and WVU Hospitals and Clinics
Canonsburg, Pennsylvania
Kayla Stover, Pharm.D., BCIDP, BCPS-AQ ID, FCCP, FIDSA
Associate Professor
University of Mississippi School of Pharmacy
Jackson, Mississippi
Evan Zasowski, Pharm.D., M.P.H., BCPS
Clinical Assistant Professor
University of Houston College of Pharmacy
Houston, Texas
Target Audience
These Literature Studies are designed to help board-certified pharmacists who are seeking recertification credit hours to maintain their Board of Pharmacy Specialties (BPS) Board Certification.
Learning Objectives
Continuing Pharmacy Education Credit
The American Society of Health-System Pharmacists and American College of Clinical Pharmacy are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Learning Activity |
ACPE Number |
Credit Hours |
Infectious Diseases Pharmacy Specialty Recertification Literature Study: Module 1A - HIV and Hepatitis C |
0204-9999-20-944-H01-P |
5.00 |
Infectious Diseases Pharmacy Specialty Recertification Literature Study: Module 1B - Infectious Diseases Potpourri |
0204-9999-20-945-H01-P |
3.00 |
To earn continuing pharmacy education (CPE) credit, learners must review the activity content and successfully complete the online assessments by October 20, 2020. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
Recertification Credit
Board certified pharmacists are eligible to receive up to 8 hours of recertification credit for completing this module. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by October 20, 2020. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
Technical Requirements